Evidence discovery
ACBDTAfrica Cancer BiomarkersDatabase & TechnologyContribute data
Evidence discovery
Search broadly.
Interpret carefully.
Every result declares whether it is an unreviewed literature candidate, requires full text, or has verified cohort metadata. The current dataset is synthetic and demonstrates the interface only.
Discovery workspace
Start with a marker.
Follow the evidence chain.
Search synthetic pilot fixtures by biomarker, cancer, country, entity type, clinical role, and review state.
Refine results
Offline fallbackThe evidence API is temporarily unavailable. Local synthetic fixtures are shown so the prototype remains usable.
| Review state | Open record | ||||||
|---|---|---|---|---|---|---|---|
| Protein | Liver cancer | NigerWestern Africa | Diagnostic | 2023 | Unscreened | ||
| Gene | Breast cancer | TogoWestern Africa | Risk | 2022 | Unscreened | ||
| Protein | Breast cancer | GhanaWestern Africa | Predictive | 2023 | Cohort verified | ||
| Assay panel | Cervical cancer | GhanaWestern Africa | Diagnostic | 2024 | Unscreened | ||
| Viral DNA | Cervical cancer | NigeriaWestern Africa | Risk | 2024 | Requires full text | ||
| Protein | Breast cancer | NigeriaWestern Africa | Prognostic | 2019 | Cohort verified |